Novo Nordisk completes $4.7 billion acquisition of Akero Therapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
| (NASDAQ: AKRO) | Delayed: 54.74 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.74 | 52 Week High | $ | |||
| Open | $54.74 | 52 Week Low | $ | |||
| Day High | $54.74 | P/E | N/A | |||
| Day Low | $54.74 | EPS | $ | |||
| Volume | 9,152 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 38.12 +0.06 (0.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.06 | 52 Week High | $59.00 | |||
| Open | $37.90 | 52 Week Low | $32.80 | |||
| Day High | $38.42 | P/E | N/A | |||
| Day Low | $37.90 | EPS | $0.00 | |||
| Volume | 9,341,093 | |||||
